Joseph Paduda's weblog on managed care for group health, workers compensation & auto insurance, covering health care cost containment, health policy, health research, and medical news for insurers, employers, and healthcare providers.

« What does the UAW have to do with California healthcare reform? | Main | Reform v tax breaks »

The killer drug

Sometimes it takes a few deaths for people to wake up. That appears to be the case with Fentora, the powerful narcotic manufactured by Cephalon. Four deaths have now been linked to Fentora, deaths that are all the more troubling because they appear to be from off-label use of the drug.

I'm not surprised.

Cephalon has long been accused of aggressive detailing of powerful pain meds, with Actiq the leading example. Now the company is in damage-control mode, scrambling to redo label warnings and 'warn' physicians to avoid prescribing Fentora for anything other than FDA-approved conditions.

If you're looking for a definition of hypocrisy, this is it. Despite Cephalon's PR campaign to the contrary, the company has long been accused of aggressive detailing, including efforts to encourage off-label prescribing of Actiq. The company is currently under investigation by a Congressional committee for allegedly encouraging docs to prescribe Actiq (which is closely related to Fentora) for conditions such as migraine and back pain.

What does this mean for you?

I'm wondering if payers have any liability if they approved the off-label use of Fentora for patients who subsequently died. I sincerely hope not.

Joseph Paduda is the principal of Health Strategy Associates.

Get notified by e-mail about site updates:

December 2009

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31
Powered by
Movable Type 4.261